Cart (0 Items)
Your cart is currently empty.
View Products
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG2-G4-kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Samalizumab Biosimilar - Anti-CD200 mAb - Research Grade |
|---|---|
| Source | CAS 1073059-33-2 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Samalizumab,ALXN6000,Anti-CD200,hB7V3V2 G2G4,CD200,anti-CD200 |
| Reference | PX-TA1250 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG2-G4-kappa |
| Clonality | Monoclonal Antibody |
Samalizumab has beeninvestigated for the treatment of Multiple Myeloma and B-cell Chronic Lymphocytic Leukemia.
Samalizumab Biosimilar - Anti-CD200 mAb, on SDS-PAGE under non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.